Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

Wendy De Roock, Bart Claes, David Bernasconi, +34

The Lancet Oncology

Retrospective Consortium AnalysisMedicinePathologyColorectal CancerPik3ca Mutations +3

Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

Dominique Thabut, Julien Massard, Alice Gangloff, +7

Hepatology

Glomerular DiseaseMajor Prognostic FactorsPathologySystemic Inflammatory ResponseFatty Liver Disease +20

Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic

Jean‐Jacques Tuech, Alice Gangloff, F. Di Fiore, +5

Journal of Visceral Surgery

Covid-19 EpidemicSurgical OncologyCovid-19 PandemicGastroenterologySurgery +6

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

David Sefrioui, France Blanchard, Emmanuel Touré, +19

British Journal of Cancer

Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer

David Sefrioui, Nasrin Sarafan‐Vasseur, Ludivine Beaussire, +9

Digestive and Liver Disease

EngineeringNucleic Acid BiomarkersCancer DetectionMedicineChip-based Digital-pcr Platform +11

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

Philippe Merle, Jean‐Frédéric Blanc, Jean–Marc Phelip, +90

˜The œLancet. Gastroenterology & hepatology

NanoparticlesNanomedicineSorafenib Treatment FailureOncologyHepatology +10

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)

Frédéric Di Fiore, Olivier Bouché, Côme Lepage, +11

Digestive and Liver Disease

Covid-19 EpidemicGastrointestinal OncologyMedicineCovid-19 PandemicPathology +5

Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer

Aude Di Fiore, Stéphane Lecleire, Alice Gangloff, +8

Digestive and Liver Disease

Surgical OncologyEsophagusEsophageal CancerGastrointestinal OncologyMedicine +9

CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)

David Sefrioui, Ludivine Beaussire, André Gillibert, +21

British Journal of Cancer

MedicinePathologyColorectal CancerMetastatic Colorectal CancerTumour Cell Kinetics +4

Fully versus partially covered self-expandable metal stents in benign esophageal strictures

Alice Gangloff, Stéphane Lecleire, Aude Di Fiore, +4

Diseases of the Esophagus

Fcsems PlacementSelf-expandable Metal StentsBenign Esophageal StricturesEndovascular TechniqueVascular Surgery +9